🔎 Trials Near Me

Domov › Nemalicelični pljučni rak › Illinois › Evanston

Klinične študije za Nemalicelični pljučni rak v Evanston, IL

22 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Evanston in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • NorthShore University HealthSystem-Evanston Hospital, Evanston
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mi stran
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
  • in še 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Vključevanje udeležencevFaza 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Vključevanje udeležencevFaza 3
  • Endeavor Health, Evanston
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07361497

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Vključevanje udeležencevFaza 3
  • North Shore University Health System ( Site 4014), Evanston
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Illinois Cancer Specialists, Niles · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Vključevanje udeležencevFaza 2
  • Illinois Cancer Specialists /ID# 274678, Niles · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06568939

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Vključevanje udeležencevFaza 3
  • Clinical Study Site, Evanston
Starost 18 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06767514

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

Vključevanje udeležencevFaza 2/3
  • USOR - Illinois Cancer Specialists - Niles, Niles · 6 mi stran
  • Advocate Medical Group Oncology, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT04613596

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Vključevanje udeležencevOpazovalna študija
  • Orchard Healthcare Research Inc., Skokie · 2 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT05935384

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Vključevanje udeležencevFaza 3
  • Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06345729

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Vključevanje udeležencevFaza 3
  • Research Site, Niles · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07291037

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 14. jul. 2026 · NCT06686771

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • Advocate Aurora Health, Park Ridge · 8 mi stran
Starost 18–70 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT04614103

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2/3
  • Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mi stran
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Vključevanje udeležencevOpazovalna študija
  • Advocate Lutheran General Hospital, Park Ridge · 8 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. mar. 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Vključevanje udeležencevOpazovalna študija
  • Northwestern University, Evanston
Starost 18 in več · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT05236114

Študije za Nemalicelični pljučni rak v drugih mestih

Druge študije v Evanston

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.